AstraZeneca - Statistics & Facts

In 2021, AstraZeneca generated revenues of some 36.5 billion U.S. dollars, the fourth consecutive year with significant growth. The largest therapeutic area is oncology, responsible for more than 35 percent of the company’s total revenue. Accordingly, AstraZeneca’s best-selling product is Tagrisso, a lung cancer treatment. Tagrisso generated a total revenue of five billion U.S. dollars in 2021. Other well-known products are Symbicort, Crestor, Nexium, and Pulmicort, some of which have already lost patent protection. Interestingly, although in global focus due to its COVID-19 vaccine, AstraZeneca is not among the top 10 vaccine manufacturers.

High R&D intensity as a company trait

Within big pharma, AstraZeneca is among the companies with the largest investment in research and development in relation to revenues. AstraZeneca spends well above 20 percent – in some years even nearly 30 percent – of its revenues on R&D projects. In 2021, the company’s R&D expenditures stood at more than 9.7 billion euros. As a consequence, AstraZeneca is among the companies with the highest number of originated drugs and also has one of the largest R&D pipelines worldwide.

The COVID-19 vaccine

In 2020, British-Swedish biopharmaceutical company AstraZeneca became well-known due to its highly promising COVID-19 vaccine. Codenamed AZD1222, the vaccine was the most pre-ordered COVID-19 vaccine worldwide, by far. The vaccine was originally developed at the University of Oxford’s Jenner Institute. In April 2020, the two parties announced a partnership that saw AstraZeneca take responsibility for the trials, production, marketing, and logistics. The company declared that the vaccine would be sold at cost price. Additionally, the vaccine does not require ultra-cold storage, which is different from some of the other vaccines available. Therefore, AZD1222 has become especially attractive for countries without an existing ultra-cold supply chain, as well as for developing countries.

Interesting statistics

In the following 5 chapters, you will quickly find the 23 most important statistics relating to "AstraZeneca".

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Vianny Gutierrez-Cruz
Vianny Gutierrez-Cruz
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Ziyan Zhang
Ziyan Zhang
Customer Relations– Contact (Asia)

Mon - Fri, 11:30am - 10pm (IST)

Contact Kisara Mizuno
Kisara Mizuno
Customer Success Manager– Contact (Asia)

Mon - Fri, 9:30am - 5:30pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Associate Director - LAC– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)